Consolidated Statements Of Cash Flows (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Cash Flow From Operating Activities:
Net loss	$ (54,026)	$ (39,640)
Adjustments to reconcile net loss applicable to common shares to net cash used in operating activities:
(Gain) loss on sale of land	(6,707)	6,005
(Gain) loss on sale of income producing properties	365	(3,754)
Depreciation and amortization	18,891	21,649
Impairment of notes receivable and real estate assets	31,503
Amortization of deferred borrowing costs	2,071	1,577
Earnings from unconsolidated subsidiaries and investees	(378)	122
(Increase) decrease in assets:
Accrued interest receivable	15	(343)
Other assets	(964)	8,561
Prepaid expense	2,312	815
Escrow	7,624	5,537
Earnest money	1,385	900
Rent receivables	3,712	(1,726)
Increase (decrease) in liabilities:
Accrued interest payable	3,786	1,239
Affiliate payables	(14,519)	(2,055)
Other liabilities	(6,791)	(4,324)
Net cash used in operating activities	(11,721)	(5,437)
Cash Flow From Investing Activities:
Proceeds from notes receivable	12,849	1,443
Originations or advances on notes receivable	(1,425)	(22,339)
Acquisition of land held for development		(4,937)
Acquisition of income producing properties	(13,002)
Proceeds from sale of income producing properties	106,940	146,131
Proceeds from sale of land	107,365	15,674
Proceeds from sale of investment in unconsolidated real estate entities	(9)
Proceeds from sale of investments	592
Investment in unconsolidated real estate entities	(306)	395
Improvement of land held for development	(1,270)	(1,820)
Improvement of income producing properties	(2,069)	(2,017)
Sales of controlling interest	2,047	22
Construction and development of new properties	(39,927)	(23,801)
Net cash provided by investing activities	171,785	108,751
Cash Flow From Financing Activities:
Proceeds from notes payable	101,434	122,248
Recurring amortization of principal on notes payable	(11,321)	(9,484)
Payments on maturing notes payable	(116,913)	(115,254)
Debt assumption by buyer	(147,742)	(97,772)
Deferred financing costs	(299)	(2,876)
Distributions to non-controlling interests	7	(7)
Common stock issuance	1,530
Net cash used in financing activities	(163,582)	(103,942)
Net decrease in cash and cash equivalents	(3,518)	(628)
Cash and cash equivalents, beginning of period	11,259	5,665
Cash and cash equivalents, end of period	7,741	5,037
Supplemental disclosures of cash flow information:
Cash paid for interest	38,651	47,339
Cash received for income taxes, net of payments		(48)
Schedule of noncash investing and financing activities:
Notes receivable received from affiliate		21,859
Series C Preferred Stock [Member]
Cash Flow From Financing Activities:
Preferred stock dividends	(158)	(159)
Series D Preferred Stock [Member]
Cash Flow From Financing Activities:
Preferred stock dividends	$ (673)	$ (638)